Comparative Analysis of Durable Responses on Immune Checkpoint Inhibitors Versus Other Systemic Therapies

A Pooled Analysis of Phase III Trials

Elvire Pons-Tostivint, MD; Aurélien Latouche, PhD; Pauline Vaflard, MD; Francesco Ricci, MD, PhD; Delphine Loirat, MD, PhD; Ségolène Hescot, MD, PhD; Marie-Paule Sablin, MD; Roman Rouzier, MD, PhD; Maud Kamal, PhD; Claire Morel, MSc; Charlotte Lecerf, MSc; Vincent Servois, MD; Xavier Paoletti, PhD; Christophe Le Tourneau, MD, PhD

Disclosures

JCO Precis Oncol. 2019;2019(3) 

In This Article

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....